drugset
drugset / Trial / NCT00437463

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

NCT00437463 ↗

Phase 3 Completed 60 enrolled Sanofi
RandomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy of the ACE inhibitor ramipril in the treatment of early IgA nephropathy.

Timeline

Start
2004-07
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramipril Small molecule 5 mg —

Indications

glomerulonephritis